Vertex Newswire

Vertex Newswire

Comprehensive Real-Time News Feed for Vertex.

Results 1 - 20 of 658 in Vertex

  1. Media chieftains stand atop the list of best-paid CEOs.Read the original story w/Photo

    5 hrs ago | MySanAntonio.com

    HOLD FOR RELEASE UNTIL 6:00 A.M. EDT. THIS PHOTO MAY NOT BE PUBLISHED, BROADCAST OR POSTED ONLINE BEFORE 6:00 A.M. EDT - This undated photo provided by Vertex shows company CEO Jeff Leiden.

    Comment?

  2. Novel drug combo improves function of protein underlying cystic fibrosisRead the original story w/Photo

    21 hrs ago | PhysOrg Weblog

    ... events reported were mild to moderate and included shortness of breath and chest tightness. The drugs' manufacturer, Vertex Pharmaceuticals, submitted a New Drug Application for approval of the combination therapy to the Food and Drug Administration ...

    Comment?

  3. Advisory firms urge Vertex shareholders to reject pay packagesRead the original story w/Photo

    Tuesday | Boston.com

    Two leading advisory firms are recommending shareholders vote against executive pay packages at Vertex Pharmaceuticals Inc., calling aspects of last year's compensation at the Boston biotech company "excessive" and "exorbitant." The two firms that advise large shareholders how to vote on questions presented at company annual meetings were particularly critical of $29 million in one-time retention bonuses awarded to Vertex's top five executives last year.

    Comment?

  4. Vertex Pharmaceuticals (VRTX) - Research Analysts' Weekly Ratings ChangesRead the original story

    Tuesday | AmericanBankingNews.com

    They now have a $85.00 price target on the stock. 5/14/2015 - Vertex Pharmaceuticals had its "overweight" rating reaffirmed by analysts at JPMorgan Chase & Co..

    Comment?

  5. Synthclipse 1.0.0 released.Read the original story

    Monday May 25 | OpenGL Headline News

    Synthclipse is Open Source GLSL shader prototyping tool based on Eclipse IDE. It makes possible to fast develop all kinds of shaders: Fragment , Vertex , Geometry , Tessellation and Compute .

    Comment?

  6. Lack of talent will hamper continuous manufacturing adoption, says MIT ProfRead the original story w/Photo

    Wednesday May 13 | In-PharmaTechnologist.com

    ... $29m in a plant in Singapore, Novartis is working on development of systems in collaboration with MIT, and both Vertex Pharmaceuticals and J&J were described as "early adopters" by Jamison. The deeper problem, however, lies in the lack of scientific ...

    Comment?

  7. A Beautiful Biotech Summer?Read the original story w/Photo

    Friday May 22 | Barron's

    We think the tone in the group has turned back to a bullish outlook, though the ASCO meeting can create shorter-term volatility. With the innovation wave in SMid cap picking up momentum and with an event-rich summer for large caps, we remain positive on the biotech group overall While we see scenarios for upside value across multiple companies we highlight Biogen and Alexion as having particularly favorable risk / reward profiles based on very defensible core businesses and very good pipeline / launch upside, while we do not view the potential upside for Celgene , Vertex or Amgen as compelling at this time.

    Comment?

  8. CRISPR First to Take Shared Laboratory Space at Old Vertex BuildingRead the original story

    Thursday May 21 | BioSpace

    A shared laboratory space for young biotech firms that are too big to be in an incubator space has attracted its first client three months after its launch. Mass Innovation Labs opened in February in one of the old buildings for Vertex Pharmaceuticals at 675 W. Kendall St. The 124,000 square feet of lab space takes up three floors and half of the building, which is also shared with Momenta Pharmaceuticals and Sanofi.

    Comment?

  9. Lee Ainslie Adds 90 New Stocks to His Portfolio Within the First QuarterRead the original story w/Photo

    Wednesday May 20 | GuruFocus.com

    ... one-year low of 2.28. Ainslie also aded Kraft Foods Group INC ( KRFT ), Actavis PLC ( ACT), Autodesk Inc ( ADSK ), Vertex Pharmaceuticals ( VRTX ) and Sensata Technologies Holding N.V. ( ST ). For a complete list of new positions in Ainslie's ...

    Comment?

  10. Novel Drug Combo Improves Function of Cystic Fibrosis ProteinRead the original story

    Wednesday May 20 | Newswise

    ... events reported were mild to moderate and included shortness of breath and chest tightness. The drugs' manufacturer, Vertex Pharmaceuticals, submitted a New Drug Application for approval of the combination therapy to the Food and Drug Administration ...

    Comment?

  11. Spending on big ideas brings a big pay-offRead the original story

    Wednesday May 20 | Iol.co.za

    ... in the last three years. These were mainly technology giants like Yahoo! and Adobe Systems, science pacesetters like Vertex Pharmaceuticals and Gilead Sciences, and makers of engineered products like cars, airplanes and electronics gear. Financial ...

    Comment?

  12. Gilead Sciences Buying Achillion Was Twitter Speculation at Its FinestRead the original story w/Photo

    Tuesday May 19 | TheStreet.com

    ... to make a big, transformative acquisition in another disease area where the company has only just dipped its toe. Vertex Pharmaceuticals with its growing cystic fibrosis drug has been suggested . Personally, I think Gilead should buy (or merge with) ...

    Comment?

  13. Twitter Attempts to Marry Gilead, Achillion, Finds Reality InsteadRead the original story

    Monday May 18 | BioSpace

    ... distinction is an important one, because some analysts have been pushing for Gilead to merge with larger competitor Vertex Pharmaceuticals ( VRTX ), a deal Yee apparently thinks is unnecessary. "[For Gilead ] 1) expectations are low on this program ...

    Comment?

  14. New Drug Combo Treats Cause of Most Common Form of Cystic FibrosisRead the original story

    Monday May 18 | P&T Community

    ... treated the defective CF protein and improved lung function. The drug combination would be marketed as Orkambi (Vertex Pharmaceuticals). The F508del gene mutation is found in more than half of the CF population. Approximately 8,500 people in the ...

    Comment?

  15. Drug combo helps people with common cystic fibrosisRead the original story w/Photo

    Monday May 18 | New Vision

    ... CF that affects about four percent of all patients. The other drug in the combination, lumacaftor, is also made by Vertex Pharmaceuticals, and has yet to be approved by regulators. Vertex announced earlier this week that an FDA advisory panel voted ...

    Comment?

  16. Third Rock Ventures Sniffing Around Ex-Vertex Digs in Cambridge for StartupsRead the original story

    Sunday May 17 | BioSpace

    May 18, 2015 By Riley McDermid and Alex Keown , BioSpace.com Breaking News Staff Perennial biotech venture capital favorites Third Rock Ventures has joined the scrum of companies jockeying for a presence in white-hot biotech real estate market Cambridge, Mass., saying Monday it is looking at Vertex Pharmaceuticals ' former 340,000 square foot facility. BioSpace reported Friday that the property will be re-developed to host a number of smaller biotech startups.

    Comment?

  17. New treatment brings hope on cystic fibrosisRead the original story w/Photo

    Sunday May 17 | Mail on Sunday

    ... to results of the clinical trial published in the New England Journal of Medicine. The new drug, developed by Vertex, a company based in Boston, US, is targeted at people with the most common form of cystic fibrosis known as F508del. Cystic ...

    Comment?

  18. New England Journal of Medicine Publishes Data from Two Phase 3...Read the original story

    Sunday May 17 | Freshnews

    Vertex Pharmaceuticals Incorporated today announced that the New England Journal of Medicine published data from the two Phase 3 studies of ORKAMBITM , an investigational medicine designed to treat the underlying cause of cystic fibrosis in people ages 12 and older with two copies of the F508del mutation, the most common form of the disease. The data were published online today in conjunction with the American Thoracic Society International Conference where the data were presented in a session titled, "Discussion on the Edge: Recent Pulmonary Research Published in NEJM or JAMA."

    Comment?

  19. Software, hardware short takesRead the original story

    Friday May 15 | Oil IT Journal

    Assai Software, Badleys, ClearEdge3D, IBM, Ikon Science, INT, KBC Advanced technologies, Lynx, Newgate Instruments, Oildex, Pegasus Vertex, Safran, Schlumberger, ZTR Control Systems. .... ... This article contains approximately 427 words This article contains approximately 427 words.

    Comment?

  20. a Five things you need to know today, and why Cambridge should thank Vertex for leavingRead the original story w/Photo

    Friday May 15 | Business Journal

    Good morning, Boston! Here are the five most important things you need to know to help start your busy business day: Here's what commencement season means for the Massachusetts economy Commencement season is big business for Massachusetts, as some 75,000 graduates don caps and gowns this spring and generate millions of dollars in hotel and ... (more)

    Comment?